News

CMN Weekly (15 October 2021)

Some of the best links we picked up around the internet

By: Gorm Palmgren - Oct. 15, 2021

Top picks

Research

Industry

Clinical News

COVID-19

Reviews

Opinion

  • Future Medicine brings an interview with Geoff MacKay, who talks about new gene therapies for rare diseases. MacKay is the CEO of AVROBIO, a clinical-stage lentiviral gene therapy company that treats lysosomal disorders, and a board member of Talaris Therapeutics and Satellos Bioscience.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN WeeklyHashtagAllogene Therapeutics, Inc.HashtagCRISPR Therapeutics AGHashtagIntellia Therapeutics, Inc.HashtagPoseida TherapeuticsHashtagPrecision BioSciences, Inc.HashtagSarepta Therapeutics

News: CMN Weekly (15 October 2021)
Search your next CRISPR job here...
Search your next CRISPR job here...
CLINICAL TRIALS
Beta-Thalassemia, BT, (NCT05442346)
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
T-cell Acute Lymphoid Leukaemia, ALL, (NCT05397184)
Sponsors:
Great Ormond Street Hospital for Children NHS Foundation Trust
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine